OKE vs OKUR · P/E 15, rev $21.67B vs P/E 72, rev $2.0M
ONEOK Inc (OKE) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Latest reported OKE revenue for 2026-06-30 was $21.67B. Net income was $1.74B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
OKE currently screens at market cap $53.92B and trailing P/E 15.3. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the OKE and OKUR stock pages for the full models.
Not investment advice.